Beatrice Schell

Clinical determinants of long-term survival in metastatic uveal melanoma

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancer Immunology, Immunotherapy.

Clinical determinants of long-term survival in metastatic uveal melanoma

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancer Immunology, Immunotherapy.

Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011

M. Gerken, L. Heinzerling, S. Klug, 2016, BMC Cancer.

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.

J. Utikal, C. Berking, S. Haferkamp, 2017, European journal of cancer.

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis

C. Berking, B. Schilling, K. Kähler, 2016, Cancer Immunology, Immunotherapy.

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

M. Weichenthal, J. Utikal, C. Berking, 2022, Cancers.

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancers.

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events

S. Haferkamp, A. Gesierich, K. Kähler, 2024, Frontiers in immunology.